Skip to content
CED Clinic
Contact Us Book Consultation GLP-1 Care
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
  • Facebook
  • X
  • Email
  • Instagram
  • YouTube
  • Substack
  • Dr Caplan’s Book
CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
Subscribe
Close

Search

Exclusive
Cannabis and Heart Attacks: What a New Comprehensive Review of Recreational Drug-Associated ACS Actually Shows | cannabis acute coronary syndrome review
August 30, 2026
Cannabis and Heart Attacks: What a New Comprehensive Review of Recreational Drug-Associated ACS Actually Shows
Industrial control panel with red, green, and amber indicator lights
August 30, 2026
Deadly Oklahoma THC Extraction Explosion Raises Safety Questions
How Drying and Curing Change Cannabis Chemistry
August 30, 2026
How Drying and Curing Change Cannabis Chemistry
Scientists Discover a Cannabis Receptor That Could Stop Breast Cancer Spreading
August 30, 2026
Scientists Discover a Cannabis Receptor That Could Stop Breast Cancer Spreading
Mike Robinson's Post
August 30, 2026
Mike Robinson’s Post
Study Finds CBD-Dominant Cannabis Oil Linked to Less Chronic Pain After Knee Replacement
August 30, 2026
Study Finds CBD-Dominant Cannabis Oil Linked to Less Chronic Pain After Knee Replacement
Freeze Drying Cannabis vs Curing: Terpenes, Trichomes & Potency (What the Studies Show)
August 30, 2026
Freeze Drying Cannabis vs Curing: Terpenes, Trichomes & Potency (What the Studies Show)
CBDV vs CBD: What All Six Clinical Trials Found | CBDV clinical trials
August 30, 2026
CBDV vs CBD: What All Six Registered Clinical Trials of Cannabidivarin Actually Found
CBD and Sexual Performance: Science vs. Hype
August 30, 2026
CBD and Sexual Performance: Science vs. Hype
Study Finds CBD-Dominant Cannabis Oil Linked to Less Chronic Pain After Knee Replacement
August 30, 2026
Study Finds CBD-Dominant Cannabis Oil Linked to Less Chronic Pain After Knee Replacement
"Scromiting" Is Sending Young Weed Smokers To The Hospital
August 30, 2026
"Scromiting" Is Sending Young Weed Smokers To The Hospital
Brain's cannabis-like molecules amplify reward engagement via retrograde signaling
August 30, 2026
Brain’s cannabis-like molecules amplify reward engagement via retrograde signaling
CBDV vs CBD: Two Carbons Apart, Six Trials, Mostly Null
August 30, 2026
CBDV vs CBD: Two Carbons Apart, Six Trials, Mostly Null
E-Cigarettes for Smoking Cessation: What the Newest Cochrane Review Shows, and Why It Doesn't Cover THC Vapes | e-cigarettes for smoking cessation Cochrane review
August 29, 2026
E-Cigarettes for Smoking Cessation: What the Newest Cochrane Review Shows, and Why It Doesn’t Cover THC Vapes
PleoPharma Wins $6.5 Million NIH Grant for Phase 3 Trial
August 29, 2026
PleoPharma Wins $6.5 Million NIH Grant for Phase 3 Trial
Cannabis's Expanding Role Challenges California Sober Approach to - Bioengineer.org
August 29, 2026
Cannabis’s Expanding Role Challenges California Sober Approach to – Bioengineer.org
Missouri Officials Defend Hemp Product Ban From Industry Lawsuit In Federal Court
August 29, 2026
Missouri Officials Defend Hemp Product Ban From Industry Lawsuit In Federal Court
August 29 Highly Enlightened Cannabis News | Jon Purow
August 29, 2026
August 29 Highly Enlightened Cannabis News | Jon Purow
Federal Rescheduling Sets The Stage For Marijuana Business Acquisitions As Pharma And ...
August 29, 2026
Federal Rescheduling Sets The Stage For Marijuana Business Acquisitions As Pharma And …
CBD Reduces Pain From Burning Mouth Syndrome
August 29, 2026
CBD Reduces Pain From Burning Mouth Syndrome
91% of Seniors Report Relief From Medical Cannabis, Colombia Study Shows
August 29, 2026
91% of Seniors Report Relief From Medical Cannabis, Colombia Study Shows
Study Finds Just 14% of Colorado Recreational Marijuana Products Fully Comply With State ...
August 29, 2026
Study Finds Just 14% of Colorado Recreational Marijuana Products Fully Comply With State …
Rare Cannabinoid Company Launches Guide to Endocannabinoid System and Rare Cannabinoids
August 29, 2026
Rare Cannabinoid Company Launches Guide to Endocannabinoid System and Rare Cannabinoids
Exilby: FDA Fast-Tracks Cannabis-Derived Painkiller Disrupting Multi-Billion-Dollar Opioid Industry
August 29, 2026
Exilby: FDA Fast-Tracks Cannabis-Derived Painkiller Disrupting Multi-Billion-Dollar Opioid Industry
Blood samples arranged in a clinical research laboratory
August 29, 2026
Semaglutide for MASH in Japan: What the ESSENCE Subgroup Found
macro shot of vegetable lot
August 29, 2026
Medical Nutrition Therapy in Incretin-Treated Heart Failure: A New Framework for Weight-Loss Quality
Alabama State Capitol in Montgomery, representing the state medical cannabis program behind the Talladega dispensary opening
August 29, 2026
Alabama Opens Its Second Medical Cannabis Dispensary
Your Endocannabinoid System Has A Different Job During Sleep Than When You Are Awake.
August 29, 2026
Your Endocannabinoid System Has A Different Job During Sleep Than When You Are Awake.
CBD and CBG Restored Memory in Animal Model of Iron-Related Brain Damage, Study Finds
August 29, 2026
CBD and CBG Restored Memory in Animal Model of Iron-Related Brain Damage, Study Finds
Daily Cannabis News Brief for 8/28/2026
August 29, 2026
Daily Cannabis News Brief for 8/28/2026
Cannabis Mitigates Symptoms of Restless Leg Syndrome
August 29, 2026
Cannabis Mitigates Symptoms of Restless Leg Syndrome
Home/Cannabis Science/Cannabis policy priorities and public health- a survey of elected officials in California
ced pexels 8846404
Cannabis Science

Cannabis policy priorities and public health- a survey of elected officials in California

By Benjamin Caplan, MD
16 Min Read
Comments Off on Cannabis policy priorities and public health- a survey of elected officials in California

Table of Contents

  • Cannabis Policy Priorities of Elected Officials: What the Data Show
    • Abstract
    • Study at a Glance
    • Study Snapshot
    • Study Facts Table
    • What Researchers Actually Did
    • Key Findings: Primary Outcomes
    • Key Findings: Secondary Outcomes and Subgroup Analyses
      • Tax Revenue Allocation by Party
      • Youth Prevention Strategies
      • Constituent Priorities vs. Officials’ Own Priorities
      • Partisan Convergence in Retail-Allowing Jurisdictions
      • Qualitative Themes
    • Adverse Events and Safety Profile
    • Statistical Approach and Rigor
    • Clinical Takeaway
    • Why This Matters Clinically
    • CED Clinic Relevance
      • Read This Paper Through Nine Different Lenses
        • Overview
        • Patient Takeaway
        • Clinician’s POV
        • A Skeptical Read
        • Study Critic
        • Compared to Past Research
        • Practical Considerations
        • Future Directions
        • Misreadings & Bad-Faith Takes
      • What were the top priorities of California elected officials regarding cannabis policy?
      • How did partisan differences affect support for adult-use retail licensing?
      • What percentage of California jurisdictions with retail cannabis have implemented youth-attractive packaging bans?
      • How did officials frame cannabis in their qualitative responses?
      • What was the level of cross-party agreement on restricting youth-attractive packaging?
      • How did Republicans and Democrats differ in their prioritization of adverse health effects?
      • What percentage of officials had been approached by cannabis industry representatives?
      • How did Republicans and Democrats differ in their prioritization of directing tax revenue to law enforcement?
      • What were the two most commonly cited effective strategies for reducing youth cannabis use?
      • How did officials perceive constituent priorities regarding cannabis?
  • Newsletter Signup Form
      • Read next
      • Related

Cannabis Policy Priorities of Elected Officials: What the Data Show

Cannabis Policy
Public Health
Youth Prevention
Local Government
Partisan Politics

What You’ll Learn

  • How California’s local elected officials rank cannabis policy priorities — and where public health ranks relative to revenue
  • Where partisan divides are sharpest, and where rare cross-party consensus actually exists on youth protection measures
  • Why an 84% approval rating for a health-protective packaging rule has not translated into real ordinances in the vast majority of jurisdictions
  • What the qualitative data reveal about how officials actually frame cannabis, from prohibition-era moralism to wellness narratives, and why that framing matters for evidence-based advocacy

TL;DR: Among California elected officials, economic priorities outrank health concerns, partisan divides govern most licensing and resource-allocation questions, and an 84% cross-party consensus on banning youth-attractive packaging has failed to materialize into actual law in more than 96% of jurisdictions that allow retail sales.

? Cross-Sectional Survey Study

Abstract

Background: Cannabis legalization has substantial impacts on public health across the United States, yet the perspectives of local elected officials who oversee regulatory environments and make decisions about cannabis business retail licensing, taxation, and marketing restrictions remain largely unstudied. Understanding how these policymakers prioritize health considerations relative to economic and other concerns is essential for developing effective public health advocacy and anticipating barriers to implementing health-protective cannabis regulations.

Methods: From September 2023 to February 2024, we conducted an online survey of 2,681 elected officials in California local government, assessing cannabis policy positions, priorities, and engagement. Descriptive statistics were calculated for all measures. Likelihood ratio tests using logistic regression assessed differences across political party affiliations (Democrat, Republican, Independent), with analyses stratified by whether respondents’ jurisdictions allowed cannabis retail. One open-ended measure was analyzed using thematic coding.

Results: Among 250 respondents (9.3% response rate), who were primarily city council members, 40% reported direct cannabis policy experience and 75% expressed interest in regulatory involvement. Top priorities were tax revenue (41%), economic development (41%), and youth cannabis use (38%), reflecting tension between fiscal and health considerations. Support for licensing adult-use retailers was significantly higher among Democrats (72%) than Republicans (39%; OR = 0.25 [95% CI: 0.11, 0.56]) or Independents (38%; OR = 0.23 [0.10, 0.53]). Republicans were significantly more likely to prioritize adverse health effects (47% vs. 22% Democrats; OR = 3.10 [1.36, 7.07]). Social equity was prioritized by only 13% overall, with significant partisan variation (20% Democrats vs. 3% Republicans; OR = 0.11 [0.01, 0.85]). Cross-party agreement emerged on restricting youth-attractive packaging (84%), yet fewer than 4% of California jurisdictions that allow retail to operate have implemented such protections. Qualitative responses revealed diverse framings of cannabis, from prohibition-era moral concerns to wellness narratives, suggesting policy decisions are often not evidence-based.

Conclusions: This first systematic study of U.S. elected officials’ cannabis policy positions documents a political landscape in which economic considerations predominate over health concerns and significant gaps exist between policymakers’ support for health-protective measures and actual policy implementation. These findings identify actionable opportunities for evidence-based public health advocacy, particularly in support of bipartisan youth protection measures.

Talk to Dr. Caplan

Want to apply this research to your own care?

30,000+ patients treated. Appointments in Massachusetts and via telemedicine.

Book a consultation →GLP-1 + cannabis program
BC

Dr. Benjamin Caplan, MD

Board-certified Family Medicine

20+ years in cannabis medicine. CMO, CED Clinic. Author, Penguin Random House. Principal Investigator in multiple studies.

Full bio →

Related reading

  • Conditions A–Z →
  • Cannabis & anxiety →
  • Cannabis & sleep →
  • Cannabinoid profiles →

Wherever you are

Dr. Caplan offers consultations for complex conditions and wellness needs. Patients from across the US and internationally are welcome.

Book a consultation →

Source: Whitacre R, Padon A, Simard B, Silver LD. Cannabis policy priorities and public health: a survey of elected officials in California. BMC Public Health (2026).

DOI: https://doi.org/10.1186/s12889-026-27889-x

Status: Article in Press (accepted 20 May 2026; unedited version)

PubMed: PMID not yet assigned at time of publication

Study at a Glance

Design Online cross-sectional survey with mixed-methods (quantitative + reflexive thematic analysis)
Population Elected officials and their staffers in California city, county, and state government
N (invited / responded) 2,681 invited; 250 responded (9.3% response rate)
Primary Endpoint Cannabis policy priorities and positions, including health vs. economic framing and partisan variation
Key Finding Tax revenue and economic development (each 41%) outranked health outcomes; 84% cross-party support for packaging restrictions has not translated into enforceable ordinances in over 96% of retail-allowing jurisdictions

Study Snapshot

Metric Finding
Top policy priority #1 and #2 (tied) Tax revenue (41%) and economic development (41%)
Top policy priority #3 Youth cannabis use (38%)
Democrats supporting adult-use retail licensing 72%
Republicans supporting adult-use retail licensing 39% (OR = 0.25 [0.11, 0.56] vs. Democrats)
Republicans prioritizing adverse health effects 47% vs. 22% Democrats (OR = 3.10 [1.36, 7.07])
Social equity as a top priority (overall) 13% overall; 20% Democrats vs. 3% Republicans (OR = 0.11 [0.01, 0.85])
Cross-party support for banning youth-attractive packaging 84%
Jurisdictions with retail that enacted such packaging rules 12 of 320 (<4%)
Republicans prioritizing law enforcement for tax revenue 71% vs. 28% Democrats (OR = 6.47 [2.75, 15.23])
Officials approached by cannabis industry representatives 54% (across all parties)

Study Facts Table

Field Detail
Authors Ryan Whitacre, Alisa Padon, Bethany Simard, Lynn D. Silver
Journal BMC Public Health
Year 2026 (Article in Press)
Design Cross-sectional online survey with thematic analysis of open-ended responses
N 250 respondents from 2,681 invited (9.3% response rate); partisan analysis n = 155
Population City council members, county supervisors, county sheriffs, district attorneys, state legislators, and their staffers in California
Intervention Not applicable (observational survey)
Primary Endpoint Cannabis policy priorities, positions on regulatory measures, and partisan variation in both
Key Results Tax revenue and economic development tied as top priorities (41% each); youth use third (38%); 84% cross-party support for packaging restrictions vs. <4% implementation; significant partisan divides on licensing, equity, and tax allocation
Adverse Events Not applicable
Funding University of California Tobacco-Related Diseases Research Program (Agreement No. T32IR5110)
Conflicts of Interest LDS reports financial support from the University of California Office of the President; all other authors declare no competing interests

What Researchers Actually Did

Between September 2023 and February 2024, the research team deployed an online survey to 2,681 California elected officials and their staffers — spanning city council members, county supervisors, sheriffs, district attorneys, and state legislators — whose email addresses were publicly listed on jurisdiction websites. Four reminder contacts were sent over a 19-week window. The instrument covered four domains: prior cannabis policy experience and barriers to engagement; substantive policy priorities (respondents’ own and their perception of constituents’); positions on specific regulatory measures (retail licensing, packaging, marketing, delivery, taxation, and revenue allocation); and stakeholder input received. Four items used a forced-choice “top three” format to reveal true priority ordering rather than global endorsement. Jurisdiction retail status as of January 1, 2024, was drawn from the Public Health Institute’s California Cannabis Policies database and used to stratify all logistic regression analyses.

Statistical comparisons across Democrats, Republicans, and Independents used likelihood ratio tests from logistic regression, with Bonferroni-corrected Z-tests for significant pairwise comparisons. Quasi-complete separation, encountered in several low-frequency cells, was handled with Firth penalized likelihood regression. Sixty-two respondents (25%) provided open-ended text, analyzed via reflexive thematic analysis using a hybrid deductive-inductive coding strategy aligned with Braun and Clarke’s framework. A second coder independently reviewed a subset of responses, with discrepancies resolved by consensus. The quantitative and qualitative streams were triangulated to produce the final thematic synthesis.

Key Findings: Primary Outcomes

  • Economic priorities dominate: Tax revenue and economic development were each named a top-three priority by 41% of respondents, tied for first. Youth cannabis use ranked third at 38%.
  • Partisan divide on licensing: Democrat support for adult-use retail licensing (72%) substantially exceeded Republican support (39%; OR = 0.25 [95% CI: 0.11, 0.56]) and Independent support (38%; OR = 0.23 [0.10, 0.53]). In jurisdictions already allowing retail, this gap narrowed to non-significance (D: 78%, R: 70%; OR = 0.64 [0.14, 2.90]).
  • Republicans more likely to prioritize adverse health effects: 47% of Republicans listed adverse health or social effects of cannabis use as a top-three priority, compared with 22% of Democrats (OR = 3.10 [1.36, 7.07]).
  • Social equity neglected across the board: Only 13% overall named social equity a top priority. The figure was 20% among Democrats and 3% among Republicans (OR = 0.11 [0.01, 0.85]).
  • Cross-party consensus on packaging: 84% of respondents supported prohibiting packaging attractive to youth, with no statistically significant partisan difference. Despite this, only 12 of 320 California jurisdictions allowing retail had enacted regulations improving upon the state’s vague standard.
  • Cannabis industry access to policymakers: 54% of respondents had been approached by cannabis industry representatives — the same frequency as private citizens (56%).
  • General engagement: 75% of respondents expressed being somewhat or very interested in cannabis industry regulation; 59% considered cannabis policy a priority.

Key Findings: Secondary Outcomes and Subgroup Analyses

Tax Revenue Allocation by Party

Republicans prioritized directing cannabis tax revenue to law enforcement at a rate of 71%, compared with 28% among Democrats (OR = 6.47 [2.75, 15.23]) and 43% among Independents (OR = 0.31 [0.12, 0.81]). This disparity widened within retail-allowing jurisdictions: an estimated 95% of Republicans in those jurisdictions ranked law enforcement first, compared with 28% of Democrats (OR = 54.31 [2.99, 988.09]) — a finding where the confidence interval width signals a small-cell problem and warrants interpretive caution. Democrats were more likely to prioritize supporting vulnerable youth (29% vs. 11% Republicans; OR = 0.29 [0.09, 0.91]).

Youth Prevention Strategies

The two most commonly cited effective strategies for reducing youth cannabis use were limiting products mimicking candies or foods attractive to children (55%) and eliminating the illicit market (53%). Fewer than one in five respondents endorsed using tax revenue for youth programs (19%), establishing larger retailer buffer zones (16%), or education campaigns (16%). Democrats more frequently endorsed dedicating tax revenue for youth programs (28% vs. 8% Republicans; OR = 0.23 [0.06, 0.81]).

Constituent Priorities vs. Officials’ Own Priorities

When asked to characterize constituent priorities, officials ranked negative health impacts of youth use first (42%), followed by eliminating the illicit market (36%) and negative community impacts of cannabis businesses (35%). Republicans were significantly more likely to identify negative health impacts of cannabis consumption (not just youth use) as a constituent priority (34%) relative to Democrats (11%; OR = 4.10 [1.56, 10.76]).

Partisan Convergence in Retail-Allowing Jurisdictions

In jurisdictions where retail cannabis was already permitted, partisan differences in support for licensing medical and adult-use retailers were statistically non-significant between Democrats and Republicans. This convergence may reflect either normalization of legal retail or baseline self-selection of less divided jurisdictions into allowing retail in the first place.

Qualitative Themes

Open-ended responses revealed framings spanning prohibition-era moralism (“the dumbing down of America”; “eating away at the fabric of our community”), wellness narratives (“legal, regulated cannabis is not a dangerous drug”), informed public-health thinking (concerns about edible dosing, rising mental health diagnoses in young adults), and pragmatic market concerns (illicit market competition, over-regulation, insufficient medical access in rural communities). These framings coexisted across regions and do not track cleanly onto party affiliation.

Adverse Events and Safety Profile

Not applicable to a survey study of elected officials. No pharmacological intervention was assessed. The paper does, however, document that respondents perceived the illicit cannabis market as a safety threat, including concerns about fentanyl-contaminated products reaching youth and pesticide-laden illegal cannabis entering licensed facilities — framing these as population-level safety signals requiring regulatory action rather than clinical adverse events.

Statistical Approach and Rigor

The primary analytic strategy — likelihood ratio tests from logistic regression with Bonferroni-corrected pairwise Z-tests — is appropriate for the research questions posed. The use of Firth penalized likelihood regression to handle quasi-complete separation in sparse cells (e.g., Republicans with zero experience in certain policy areas) reflects methodological awareness; however, several resulting confidence intervals are very wide and should be treated as directional rather than precise estimates. Stratification by local retail policy adds important contextual resolution. The forced-choice “top three” format prevents artificial inflation of endorsement rates and is well-suited to priority elicitation in time-constrained official samples. The reflexive thematic analysis of open-ended responses follows an established framework (Braun and Clarke), with inter-rater reliability addressed through independent subset coding and consensus resolution. The triangulation of quantitative and qualitative findings is explicit and methodologically coherent. The cross-sectional design, 9.3% response rate, and the 36% of respondents who declined to provide party affiliation are the main threats to inferential validity.

Clinical Takeaway

The decisions that most directly shape the cannabis exposure environment — retail density, product type restrictions, packaging rules, marketing limitations — are made by local elected officials whose stated priorities are overwhelmingly fiscal, not clinical. Public health practitioners and cannabis clinicians who assume that evidence alone will move local policy are operating under a miscalculation. The data show that 84% of officials already support packaging restrictions that demonstrably reduce youth appeal; the bottleneck is not attitude, it is translation into ordinance. That gap is likely maintained by industry lobbying, competing municipal priorities, and limited regulatory technical capacity — not policymaker ignorance of the issue. Effective clinical-to-policy translation will require direct engagement with local decision-makers, not just publication of additional health outcome studies.

Clinical Bottom Line: Local cannabis regulatory environments, which directly affect patient exposure, use patterns, and health outcomes, are governed primarily by economic priorities and partisan dynamics — not by the clinical evidence that health professionals generate and publish.

Why This Matters Clinically

Research cited within this paper has established that retail outlet density near homes is associated with increased adolescent cannabis use, problematic use, and cannabis use during pregnancy; that local retail bans and longer drive times to the nearest retailer correlate with lower prevalence of psychotic disorder diagnoses in California adolescents; and that frequent adolescent use increased post-legalization specifically in communities allowing storefront retail. These are not theoretical regulatory risks — they are observed epidemiological signals with direct clinical relevance to the patients seen in cannabis medicine and general practice. The present survey reveals that the officials making the licensing, density, packaging, and taxation decisions driving these outcomes are operating primarily from fiscal frames and are reaching those decisions in a political environment where the cannabis industry has achieved access parity with private citizens. For clinicians ordering cannabis for patients with anxiety, psychosis risk, or prenatal concerns, the local regulatory environment is as clinically relevant as the pharmacology.

CED Clinic Relevance

At CED Clinic, patients and families frequently ask whether the cannabis they or their loved ones use is safe, properly labeled, appropriately dosed, and not marketed to children. This paper provides a structural answer to why those assurances are not consistently available: the local officials best positioned to enact packaging standards, marketing restrictions, and potency labeling requirements rank those protections well below revenue generation and market development. Patients residing in jurisdictions that allow retail are exposed to a product environment that has not been systematically bounded by the health-protective regulations that 84% of their own elected officials claim to support. That gap between stated preference and enacted law is the central policy failure this paper documents. For CED Clinic patients, particularly adolescents, pregnant individuals, and those with mental health comorbidities, this regulatory vacuum is clinically material — not peripheral.

Evidence Watch Reading Tool

Read This Paper Through Nine Different Lenses

The same evidence can produce very different conclusions depending on the question being asked. Explore this study through multiple physician-guided interpretive frameworks.

OVERVIEW
California officials prioritize economic gains over health in cannabis policy.








Overview

Badge 1: ValueBadge 2: ValueBadge 3: Value

This study highlights the significant economic focus of California elected officials in cannabis policy, overshadowing health concerns. Despite a strong cross-party agreement on youth packaging bans, implementation remains largely unenforced.

The research underscores the need for evidence-based advocacy to bridge the gap between policymakers’ support and actual policy outcomes, particularly in protecting youth from cannabis use.

  • Economic priorities dominate over health concerns.
  • Cross-party consensus exists on youth packaging bans but is not implemented.
  • Advocacy can help align policy with public health goals.
Key Insight
Economic benefits are prioritized over health in cannabis policy, despite cross-party agreement on youth protection measures.

Patient Takeaway

Badge 1: ValueBadge 2: Value

Patients should be aware that while there is strong support for protecting youth from attractive packaging, this has not yet been implemented in most jurisdictions. This gap highlights the need for continued advocacy to ensure health-protective measures are enacted.

Understanding these priorities can help patients advocate more effectively for policies that protect public health.

  • Youth protection measures lack implementation.
  • Advocacy is crucial for policy change.
  • Patients can play a role in promoting evidence-based policies.
Patient Takeaway
Support for youth packaging bans exists but is not implemented, highlighting the need for continued advocacy.

Clinician’s POV

Badge 1: ValueBadge 2: Value

Clinicians can use this data to inform their advocacy efforts, focusing on evidence-based policies that protect public health. The gap between support and implementation of youth protection measures underscores the need for targeted interventions.

Understanding these priorities can help clinicians better communicate with policymakers about the importance of health-protective regulations.

  • Clinicians should advocate for evidence-based policies.
  • Youth protection measures lack enforcement.
  • Communication is key in policy advocacy.
Clinical Takeaway
Advocate for youth packaging bans and other health-protective measures despite current gaps in implementation.

A Skeptical Read

Badge 1: ValueBadge 2: Value

Skeptics might question the effectiveness of cross-party consensus without enforcement. This study highlights the disconnect between policy support and actual implementation, suggesting that additional measures are needed to ensure health-protective policies are enacted.

Understanding these gaps can help skeptics identify areas for reform in the legislative process.

  • Cross-party agreement does not guarantee policy change.
  • Implementation gaps exist despite consensus.
  • Reform is needed in legislative processes.
Skeptic Takeaway
Cross-party support for youth packaging bans exists but lacks enforcement, indicating a need for legislative reform.

Study Critic

Badge 1: ValueBadge 2: Value

Critics can point to the economic focus of policymakers as a potential conflict of interest. The study reveals that while health is a concern, it is often secondary to economic priorities, raising questions about the balance between fiscal and public health goals.

Understanding these priorities can help critics highlight areas where policy may not align with public health objectives.

  • Economic focus may conflict with health goals.
  • Health concerns are secondary to economic priorities.
  • Critics should address potential conflicts of interest.
Critical Takeaway
Economic priorities dominate over health, raising questions about the balance between fiscal and public health goals.

Compared to Past Research

Badge 1: ValueBadge 2: Value

Past research has often focused on the impacts of cannabis legalization but rarely examined the perspectives of local elected officials. This study fills a gap by providing insights into how policymakers prioritize health versus economic considerations.

Historical data can be compared to this new information to track changes in policy priorities over time.

  • Past research lacked focus on official perspectives.
  • This study provides unique insights into policy priorities.
  • Comparison with historical data is possible.
Historical Context
This study fills a gap by examining the priorities of local elected officials, providing new insights into cannabis policy.

Practical Considerations

Badge 1: ValueBadge 2: Value

Practically, this research can guide advocacy efforts to prioritize health-protective measures. The strong support for youth packaging bans suggests that targeted campaigns could be effective in pushing for implementation.

Understanding these priorities can help stakeholders align their advocacy with the most supported policies.

  • Advocacy should focus on evidence-based policies.
  • Youth protection measures have broad support.
  • Stakeholders can align advocacy efforts effectively.
Practical Takeaway
Focus advocacy on youth packaging bans and other health-protective measures with strong cross-party support.

Future Directions

Badge 1: ValueBadge 2: Value

Future research could explore the reasons behind the gap between policy support and implementation. Understanding these barriers can inform strategies to improve enforcement of health-protective measures.

This study sets a foundation for further investigation into the legislative process and policy outcomes.

  • Explore barriers to policy implementation.
  • Further research is needed on legislative processes.
  • Set a foundation for future studies.
Future Research
Investigate barriers to implementing health-protective policies to improve enforcement.

Misreadings & Bad-Faith Takes

Badge 1: ValueBadge 2: Value

A common misreading of this study might be that cross-party consensus guarantees policy change. However, the research clearly shows that support does not translate into implementation in most jurisdictions.

Understanding these gaps is crucial to avoid oversimplifying the legislative process and its challenges.

  • Cross-party agreement does not guarantee policy change.
  • Implementation gaps are significant.
  • Avoid oversimplifying legislative processes.
Misreading Alert
Cross-party support for youth packaging bans exists but does not translate into implementation, highlighting the complexity of legislative processes.

Have thoughts on this? Share it:

X Share on X
in Share on LinkedIn
? Share on BlueSky
? Follow on Instagram
? Read more on Substack
? Subscribe via RSS
RELATED READING AT CED CLINIC
Continue exploring the evidence
Understanding the Endocannabinoid System

A physician-authored primer on ECS biology, receptor function, and why the system matters for clinical cannabis care.

Explore evidence

Cannabis for Pain Management: Smarter Ways to Match Products to Symptoms

A practical explainer on how pain timing, formulation selection, and cannabinoid ratios influence real-world outcomes.

Read article

Cannabis and Sleep: What the Evidence Actually Shows

A review of cannabinoid effects on sleep architecture, with clinical guidance for patients using cannabis for insomnia or sleep disruption.

Continue reading

CED Clinic logo
Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance
Leave a Message
Metabolic Care
Medical Consulting
Cannabis Care
Dr. Benjamin Caplan

What were the top priorities of California elected officials regarding cannabis policy?

The top priorities were tax revenue (41%), economic development (41%), and youth cannabis use (38%).

How did partisan differences affect support for adult-use retail licensing?

Support was significantly higher among Democrats (72%) than Republicans (39%) or Independents (38%).

What percentage of California jurisdictions with retail cannabis have implemented youth-attractive packaging bans?

Fewer than 4% of such jurisdictions have enacted these protections.

How did officials frame cannabis in their qualitative responses?

Responses varied from prohibition-era moral concerns to wellness narratives, indicating that policy decisions are often not evidence-based.

What was the level of cross-party agreement on restricting youth-attractive packaging?

There was an 84% cross-party support for such restrictions.

How did Republicans and Democrats differ in their prioritization of adverse health effects?

Republicans were significantly more likely to prioritize adverse health effects (47%) compared to Democrats (22%).

What percentage of officials had been approached by cannabis industry representatives?

54% of respondents reported being approached by cannabis industry representatives.

How did Republicans and Democrats differ in their prioritization of directing tax revenue to law enforcement?

Republicans prioritized directing cannabis tax revenue to law enforcement at a rate of 71%, compared with 28% among Democrats.

What were the two most commonly cited effective strategies for reducing youth cannabis use?

The two most cited strategies were limiting products mimicking candies or foods attractive to children (55%) and eliminating the illicit market (53%).

How did officials perceive constituent priorities regarding cannabis?

Officials ranked negative health impacts of youth use first, followed by eliminating the illicit market and negative community impacts of cannabis businesses.

  • Newsletter Signup Form

    Enter your email address to subscribe to our newsletter.
  • Should be Empty:

Read next

Cannabis and Heart Attacks: What a New Comprehensive Review of Recreational Drug-Associated ACS Actually Shows

Related

Tags:

California cannabis retail licensingcannabis policyElected OfficialsPartisan differences in cannabis policyPublic healthYouth-attractive packaging regulations
Author

Benjamin Caplan, MD

Follow Me
Other Articles
ced pexels 19794774
Previous

Clinical Management of Weight Regain and Cardiometabolic Consequences After Discontinuing GLP-1s

ced pexels 8016897
Next

Cancer Incidence Among Users of Glucagon‑Like Peptide‑1 Receptor Agonists

Book Now Intake Form
Dr. Benjamin Caplan, MD Learn About Dr. Caplan
Copyright 2026 — CED Clinic. All rights reserved.

Questions about this research?

Talk to Dr. Caplan →
CED Clinic
CED Clinic Home
Explore
Cannabis Science
Research & Clinical
Cannabis News
Policy, Humor & News
Metabolic Health
GLP-1 Care & Science
Cannabis Recipes
Infused Foods & Drinks
Book an Appointment Contact CED Clinic
Recent Posts
Loading…
MENU